This invention relates to a method of treating allergic, dermatologic and rheumatic diseases in mammals which comprises daily orally administering to said mammal in a single dose an effective amount of 6- chloro-11&bgr;,17&agr;,21-trihydroxypregna-1,4,6-triene-3,20-dione.
展开▼